Noticeboard

Applications are now open for My Name'5 Doddie's 2025 Advancing Treatment Awards.

These awards are designed to support the early-stage development of new treatments to slow, stop or reverse MND disease progression. These may also be treatments which could help better manage the symptoms of MND. 

Applications are encouraged for projects with the potential to be effective for a broad range of people living with MND. 

The Award, of up to £500,000 over 5 years, aims to help researchers build data packages that will attract onward investment and strategic partnerships to accelerate promising treatments through further testing and towards commercialisation.

Expressions of interest due:  Friday 2nd May (12pm)

Find out more and submit expression of interest

The ENCALS young investigator award recognises the brightest and best young scientists in ALS, and is given for outstanding research. 

Researchers must be working on a project which is novel, challenges  existing ideas about ALS, results in patient benefit, or impacts on our understanding of ALS. The competition is open to researchers aged 35 or younger on 1 September 2025, or who will be within 8 years of having been awarded their PhD if a basic scientist, or still in training (Resident or Fellow) if a medical graduate. Adjustments are made for career breaks. Researchers must be based at a university or ALS Centre in Europe, Turkey or Israel. 

Deadline for award submissions: 5 May.

Find out more and apply

Applications are now open for My Name'5 Doddie's 2025 Discovery Network Awards.

These awards are designed to catalyse the search for new effective treatments for MND.

The Discovery Network Awards provide the opportunity for interdisciplinary, multi-institutional teams to apply for £1 million over 3 years. 

Teams will take on bold ideas and innovative approaches to better understand the biology of MND, with a focused goal of identifying new therapeutic targets. The Network will be underpinned by a culture of collaboration and open science. 

Expressions of interest due:  Wednesday 21 May (12pm)

Find out more and submit expression of interest

The Radala Foundation is looking for established, leading principal investigators eligible for 200,000 CHF (~£181,500 GBP) research funding to pursue a potentially ground-breaking, high-risk project for 2 years in basic research in ALS. 

Principal Investigators (PI) are expected to be active researchers who have a track-record of significant research achievements in the last 10 years. Investigators active in ALS research or in broadly related fields are encouraged to submit proposals relevant to ALS. Research must be conducted in a public or private research organisation (known as a host institution).

The goal of the Radala foundation is to provide research grants for the study of the understanding of the basic causes of the disease. These awards are not directed to clinically related projects for patient care. There is no geographical limitation to the recipients of these grants. 

Application deadline: 30 June 2025

Find out more and apply

The Frick Foundation is looking for talented early-career scientists who have already produced excellent supervised work, ready to work independently and shows potential to be a research leader. Post-doctoral fellows are not eligible. Two researchers will receive 100,000 Swiss francs (~£90,700 GBP) each that can be used over 2 years.

Researchers of any nationality with 5 years of experience since completion of their PhD, a scientific track record showing great promise and an excellent research proposal can apply.

Research must be conducted in a public or private research organisation (known as a host Institution).

Application Deadline: 30 June 2025

Find out more and apply

The Corsalex Postdoctoral Fellowship Program is designed to support promising early-career researchers who wish to enter or continue research in the field of C9orf72 MND/FTD. 

Fellows receive up to $210,000 over 3 years to support research of high scientific merit and relevance to C9 MND.

Applications are open to Junior postdoctoral researchers with a designated advisor in an ALS or FTD-focused lab. Researchers must be no more than 1 year into postdoctoral fellowship.

Corsalex are interested in projects that focus on:

• The underlying biology of C9orf72 MND/FTD
• Novel drug targets or biomarkers
• Gene therapies
• Drug delivery into the CNS
• Disease models

Application Deadline: 1 July

Find out more and apply

The Sean M. Healey International Prize for Innovation in ALS is now accepting nominations.

The annual Sean M. Healey International Prize for Innovation in ALS is a global prize celebrating excellence in research for a team of investigators who catalyse exceptional discoveries leading to a transformative advance in therapy development in ALS. 

The award will be presented at the International Symposium on ALS/MND in San Diego, USA on the 5-7 December 2025. The selected nominee will be awarded $50,000 USD and travel reimbursement up to $2,500 USD to attend International Symposium on ALS/MND.

Prize Criteria

Team of investigators who made a significant advance in the ALS field impacting the development of novel therapies for ALS, including, but not limited to the following:

• A technology to identify novel targets for drug development
• A technology to advance therapy development for ALS
• Tools or targets to stratify the ALS population and improve clinical trial design
• A global, multiple disciplinary collaboration that leads to new insights into the biology of the disease and translates into novel approaches for therapy development
• A novel outcome measure to improve efficiency in clinical trials in patients with ALS

Nomination Deadline: Wednesday 9 July, 5PM EDT/10PM BST

Find out more and apply 

University College London are holding a three day course to provide the latest updates on neuromuscular disorders.

The course covers a wide range of childhood and adult neuromuscular disorders with an emphasis on clinical issues, natural history studies, disease specific treatments and general management. 

It is designed for specialists with an interest in neuromuscular diseases, and will also be relevant to anyone wishing to update their knowledge of neuromuscular diseases such as neurology trainees, consultants or other clinicians working with neuromuscular patients.

This course is being held from the 28-30 May at Queen Square, London. 

Find out more and register

The European Network for the Cure of ALS (ENCALS) aims to develop a European trial network and initiate collaborations in Europe. Membership is open to Universities/Hospitals in Europe with ALS clinical/research activity. 

The ENCALS meeting 2025 will be held in Turin, Italy from 3 to 6 June. 

Register and Find out more

World Congress of Neurology are committed to delivering a high-level scientific program, an international stage for your research, and plenty of networking opportunities. The XXVII World Congress of Neurology (WCN 2025) will take place on 12-15 October 2025 and will be held in Seoul, Korea.

Find out more and register

The key to defeating MND lies in fostering strong collaboration between leading researchers around the world, and sharing new understanding of the disease as rapidly as possible. This was the MND Association’s rationale behind the creation of the International Symposium on ALS/MND.

Each year, the Symposium attracts over 1,000 delegates, representing the energy and dynamism of the global MND research community. It is the largest medical and scientific conference specific to MND/ALS and is the premier event in the MND research calendar for discussion on the latest advances in research and clinical management. 

The 36th Symposium will be held in San Diego, USA in December.

Abstract submission and registration opens: Tuesday 6th May

Find out more